{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T16:09:59Z","timestamp":1784045399678,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.canep.2026.103145","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:01:57Z","timestamp":1782172917000},"page":"103145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mammography screening in women aged 39\u201349 years: Updated randomized evidence and implications for screening policy"],"prefix":"10.1016","volume":"103","author":[{"given":"Pedro C. Abrah\u00e3o","family":"Reis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Pedro","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Macambira","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathi","family":"Vellaichamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Braga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio Y.","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Cagnacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caio Dabbous","family":"de Liz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2026.103145_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jama.2017.19130","article-title":"Association of screening and treatment with breast cancer mortality by molecular subtype in US Women, 2000-2012","volume":"319","author":"Plevritis","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2026.103145_bib2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/jwh.2010.2098","article-title":"Effectiveness of mammography screening in reducing breast cancer mortality in women aged 39\u201349 Years: A Meta-Analysis","volume":"20","author":"Magnus","year":"2011","journal-title":"J. Women\u2019S. Health"},{"key":"10.1016\/j.canep.2026.103145_bib3","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/1468-0009.12583","article-title":"Why Was the US Preventive Services Task Force\u2019s 2009 Breast Cancer Screening Recommendation So Objectionable? A Historical Analysis","volume":"100","author":"Lerner","year":"2022","journal-title":"Milbank Q."},{"key":"10.1016\/j.canep.2026.103145_bib4","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJMp2307229","article-title":"The New USPSTF Mammography Recommendations \u2014 A Dissenting View","volume":"389","author":"Woloshin","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2026.103145_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"on behalf of the U.S. Preventive Services Task Force. Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.canep.2026.103145_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.52688","article-title":"Changes to the US Preventive Services Task Force Screening Guidelines and Incidence of Breast Cancer","volume":"7","author":"Zhang-Petersen","year":"2024","journal-title":"JAMA Netw. Open."},{"key":"10.1016\/j.canep.2026.103145_bib7","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ijc.30794","article-title":"Benefits and harms of breast cancer screening with mammography in women aged 40\u201349 years: A systematic review","volume":"141","author":"Van Den Ende","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canep.2026.103145_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/jbi\/wbab099","article-title":"The Fundamental Flaws of the CNBSS Trials: A Scientific Review","volume":"4","author":"Seely","year":"2022","journal-title":"J. Breast Imaging"},{"key":"10.1016\/j.canep.2026.103145_bib9","article-title":"Screening for breast cancer with mammography","volume":"2013","author":"G\u00f8tzsche","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.canep.2026.103145_bib10","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1001\/jama.2023.25844","article-title":"Screening for Breast Cancer: Evidence Report and Systematic Review for the US Preventive Services Task Force","volume":"331","author":"Henderson","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2026.103145_bib11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.canep.2026.103145_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/M15-0969","article-title":"Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.canep.2026.103145_bib13","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1177\/21925682211029640","article-title":"Risks, Rates and Odds: What\u2019s the Difference and Why Does It Matter?","volume":"11","author":"Dettori","year":"2021","journal-title":"Glob. Spine J."},{"key":"10.1016\/j.canep.2026.103145_bib14","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdg322","article-title":"The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation","volume":"14","author":"Duffy","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canep.2026.103145_bib15","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.canep.2026.103145_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jncimono\/1997.22.27","article-title":"Periodic Screening for Breast Cancer: The HIP Randomized Controlled Trial","volume":"1997","author":"Shapiro","year":"1997","journal-title":"JNCI Monogr."},{"key":"10.1016\/j.canep.2026.103145_bib17","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(98)07413-3","article-title":"14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening","volume":"353","author":"Alexander","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.canep.2026.103145_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0969141316648987","article-title":"Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malm\u00f6, Stockholm, and G\u00f6teborg","volume":"24","author":"Nystr\u00f6m","year":"2017","journal-title":"J. Med. Screen."},{"key":"10.1016\/j.canep.2026.103145_bib19","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(20)30398-3","article-title":"Effect of mammographic screening from age 40 years on breast cancer mortality (UK Age trial): final results of a randomised, controlled trial","volume":"21","author":"Duffy","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canep.2026.103145_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/jncimono\/1997.22.87","article-title":"Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials","volume":"1997","author":"Hendrick","year":"1997","journal-title":"JNCI Monogr."},{"key":"10.1016\/j.canep.2026.103145_bib21","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/08465371221148134","article-title":"Screening with breast cancer mammography: re-evaluation of current evidence","volume":"74","author":"Salameh","year":"2023","journal-title":"Can. Assoc. Radiol. J."},{"key":"10.1016\/j.canep.2026.103145_bib22","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0033-8389(05)70191-3","article-title":"The swedish two-county trial twenty years later","volume":"38","author":"Tab\u00e1r","year":"2000","journal-title":"Radiol. Clin. North. Am."},{"key":"10.1016\/j.canep.2026.103145_bib23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamaoncol.2025.1209","article-title":"Tomosynthesis vs digital mammography screening in women with a family history of breast cancer","volume":"11","author":"Li","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canep.2026.103145_bib24","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/jnci\/djab063","article-title":"Comparative effectiveness of digital breast tomosynthesis for breast cancer screening among women 40-64 years old","volume":"113","author":"Richman","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canep.2026.103145_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112088","article-title":"Cost effectiveness of digital breast tomosynthesis for breast cancer screening in a Swedish setting","volume":"187","author":"Fridhammar","year":"2025","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.canep.2026.103145_bib26","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1001\/jama.2023.24766","article-title":"Collaborative modeling to compare different breast cancer screening strategies: a decision analysis for the US preventive services task force","volume":"331","author":"Trentham-Dietz","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2026.103145_bib27","article-title":"Risk-based vs annual breast cancer screening: the WISDOM randomized clinical trial","author":"Esserman","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2026.103145_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(25)02464-X","article-title":"Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trial","volume":"407","author":"Gommers","year":"2026","journal-title":"Lancet"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778212600161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778212600161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:39:55Z","timestamp":1784043595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187778212600161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":28,"alternative-id":["S187778212600161X"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2026.103145","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mammography screening in women aged 39\u201349 years: Updated randomized evidence and implications for screening policy","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2026.103145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103145"}}